90 FR 34 pg. 10048 - Foreign-Trade Zone (FTZ) 49; Authorization of Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey
Type: NOTICEVolume: 90Number: 34Page: 10048
Page: 10048Docket number: [B-56-2024]
FR document: [FR Doc. 2025-02919 Filed 2-20-25; 8:45 am]
Agency: Commerce Department
Sub Agency: Foreign-Trade Zones Board
Official PDF Version: PDF Version
[top]
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-56-2024]
Foreign-Trade Zone (FTZ) 49; Authorization of Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey
On October 18, 2024, Merck, Sharp & Dohme LLC submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 49Y, in Rahway, New Jersey.
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (89 FR 87542-87543, November 4, 2024). On February 18, 2025, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including section 400.14.
Dated: February 18, 2025.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2025-02919 Filed 2-20-25; 8:45 am]
BILLING CODE 3510-DS-P